Data science and artificial intelligence
We’ve been using data science, artificial intelligence (AI) and machine learning (ML) to help overco...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
We’ve been using data science, artificial intelligence (AI) and machine learning (ML) to help overco...
Source route
Continue on merck.com
Leave the platform to read the original full article on the publisher site.
Source: Merck (MSD) News
Scope: Industry
Related coverage
More related coverage
Imfinzi plus Imjudo combined with lenvatinib and TACE demonstrated a statistically significant and clinically meaningful improvement in progression-free survival in embolisation-eligible unresectable liver cancer in EMERALD-3 Phase III trial
Positive high-level results from the EMERALD-3 Phase III trial showed AstraZeneca’s Imfinzi (durvalu...
teva to host conference call to discuss first quarter 2026 financial results at 8 a
TEL AVIV, Israel and PARSIPPANY, N.J., March 19, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Indust...